Observatoire des droits humains (anglais seulement)

EU, Drugmakers Commit $350 Million for Ebola Research

(Version anglaise seulement)

The European Union and drugmakers pledged on Thursday to invest 280 million euros ($350 million) in Ebola research, with the lion's share going to the testing and manufacturing of potential vaccines. The funding will go toward efforts backed by the Innovative Medicines Initiative (IMI), a public-private project jointly paid for by the European Commission and the pharmaceuticals industry. Reuters reported on October 22 that an IMI investment of around 200 million euros was pending....

Lire l'article complet